Most drug manufacturers end up investing more than USD 2 billion and as long as 12 years1 in the entire process of drug discovery all the way to marketing approvals.
Clinical trials form a critical part of this process, and require oversight of participating investigators and sites to ensure protocol adherence, safety of patients, and integrity of data. However, the conventional method of site monitoring has proven to be inefficient since it accounts for 40% of clinical trial costs2, with a measly 7% return3 on the impact of data. Furthermore, with the social distancing norms and travel restrictions triggered by the COVID-19 pandemic, traditional methods of site monitoring are proving even more ineffective. A design thinking approach for risk-based centralized monitoring can offer a solution to these challenges while paving the way for more efficient and cost-effective clinical trials.
Critical Success factors – Technology and Experience Design
With the COVID-19 pandemic introducing lockdown restrictions and social distancing norms, the world around us has changed rapidly.
However,technology can act as an enabler and bring normalcy. In this context,risk-based centralized monitoring (RBM) has emerged as a viable solution to ensure the continuity of clinical trials while travel restrictions are in place.Risk-based clinical site monitoring relies on a model of centralized risk identification, control, review, reporting, and communication, without the need to visit the sites. It helps reduce costs and allocate more resources to patient safety and sites that require additional oversight. On the patient side,it reduces the effort needed in traveling to remote site locations, especially considering the current situation.
While it incorporates many aspects, data-driven smart analytics is at the core of any RBM solution. The solution must have the capability to ingest data from multiple data sources, standardize it, and present it to end-users for deriving actionable insights. For this to happen in time, technology is pivotal. However,another important, yet often ignored, aspect is the in-depth understanding of personalized user needs and a design that fulfills it.
Successful implementation of RBM requires a user-centric design approach,the right technology, a well-defined centralized monitoring process, and an integrated team of stakeholders aligned to a common goal.
Design Thinking – Creating the Right Start
Design thinking workshops can help bring all the stakeholders together and establish consensus around the expectations from an RBM solution.
It provides a common platform where people from different regions and backgrounds can share their diverse experiences. Since each participant in the workshop has a unique vision of what the final product may look like, a comprehensive view can be created right from the start.
For instance, the vice president of a large American pharmaceutical firm shared an interesting perspective during their RBM journey. He envisioned a data-driven, smart analytics integrated solution powered by the latest AI and predictive technology, with minimal training cost and the highest level of user acceptance. Such a solution can completely transform the way RBM works in the organization. He, however, emphasized the need to make a simple and efficient system that is acceptable to the clinical research associate (CRA). CRAs are one of the key stakeholders impacted by RBM implementation. Such a fundamental shift in the process of site monitoring calls for more in-depth technical expertise and understanding from CRAs. They would not only be required to handle the system efficiently but also possess thorough knowledge of their trials, sites, and patients. This would ensure that CRAs can act as a critical link between the clinical team and the site team. Their role would also evolve to include decision-making aspect on risk analysis of a site, instead of just focusing on the compliance and accuracy of data on sites.
During our design thinking workshops, we interacted with multiple CRAs from different regions. All of them were from different backgrounds and had different stories to tell. A young CRA joined an organization with a dream to make a difference in the lives of the patients. She wanted to make the trial monitoring effective, especially in oncology trials, as one of her closest friends had cancer. She hoped for an intuitive system, with actionable insights, visual cues on the risk score of each site, timely reminders, enabling her to focus her time on high-risk sites, and protocol conduct-related problems. Another CRA was extremely good at crunching numbers and using charts and figures to make decisions. She suggested that there could be a health indicator, or a scorecard of the sites based on their risks and current performances, just like her home budget health indicator offered a sense of how her home budget was performing.
Enabling collaboration, co-creation, and democratic design can make it possible for end-users to share not only functional requirements but also unique ideas based on the daily life activities. A design-thinking approach for RBM adopts the same philosophy. Using tools like persona detailing and journey sketching, a design thinker weaves a holistic tale to put all the pieces together.
Design done right is extremely powerful and bases itself on psychological principles. It takes into account the power of the subconscious mind in influencing choices, decisions, and many unspoken requirements based on past experiences, memories, dreams, and inspirations of the end-users. For driving transformational changes according to the user needs, the focus cannot just be on the visual aesthetics; it needs to incorporate a more in-depth analysis of the unsaid needs of the user. The view must be telescopic and not microscopic.
Organizations that are just getting started with RBM can benefit significantly from design thinking workshops. These workshops can help them acquire stakeholder involvement and align everyone to a common goal. By putting together a team of experienced individuals, organizations can create a unique RBM journey.
Design Thinking – Key Aspects
Design thinking, when done right, can revolutionize the overall product experience in multiple ways. Let us look at a few key attributes:
In the life sciences segment, creativity and design play a symbiotic role in enabling solutions powered by futuristic technology.
In a world that is constrained by a pandemic, RBM solutions are the need of the hour. Design thinking helps transform the highly technical and jargon-heavy product experience into an easily understood and assimilated one that is mapped to patient needs and provides a 360-degree view of patient health. Quite figuratively, design thinking helps bring life to the sciences.